CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-16 | Paterson Dan President and COO | Sale | −15,676 | $0.40 | $6K | 466,782 |
| 2022-12-16 | Gagnon Robert E. Director | Sale | −12,408 | $0.40 | $5K | 576,146 |
| 2022-12-16 | Stuglik Brian M Chief Executive Officer | Sale | −25,162 | $0.40 | $10K | 1,126,076 |
| 2022-12-13 | Gagnon Robert E. Director | Grant or award · Stock Option (right to buy) | +153,938 | 153,938 | ||
| 2022-10-20 | Kapur Anil Director | Grant or award · Stock Option (right to buy) | +163,185 | 163,185 | ||
| 2022-09-19 | Stuglik Brian M Chief Executive Officer | Sale | −3,355 | $1.13 | $4K | 1,151,238 |
| 2022-09-19 | Paterson Dan President and COO | Sale | −2,786 | $1.13 | $3K | 482,458 |
| 2022-09-19 | Gagnon Robert E. Chief Financial Officer | Sale | −1,348 | $1.13 | $2K | 588,554 |
| 2022-08-01 | Stuglik Brian M Chief Executive Officer | Sale | −5,858 | $1.08 | $6K | 1,154,593 |
| 2022-06-22 | Solomon Lesley Kim Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-06-22 | Bunn Paul A. Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-06-22 | JOHNSON JOHN Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-06-22 | Kauffman Michael Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-06-22 | ROBERTSON MICHELLE Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-06-22 | Rowinsky Eric K Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2022-06-21 | Paterson Dan President and COO | Sale | −2,701 | $1.14 | $3K | 485,244 |
| 2022-06-21 | Stuglik Brian M Chief Executive Officer | Sale | −3,362 | $1.14 | $4K | 1,160,451 |
| 2022-06-21 | Gagnon Robert E. Chief Financial Officer | Sale | −1,351 | $1.14 | $2K | 589,902 |
| 2022-05-16 | Paterson Dan President and COO | Sale | −4,988 | $1.03 | $5K | 487,945 |
| 2022-05-16 | Stuglik Brian M Chief Executive Officer | Sale | −13,794 | $1.03 | $14K | 1,163,813 |
Page 14 of 17 · 326 trades